A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
Public ClinicalTrials.gov record NCT01519791. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate for Inducing and Sustaining Clinical Response in the Treatment of DMARD-Naïve Adults With Early Active Rheumatoid Arthritis
Study identification
- NCT ID
- NCT01519791
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB Pharma SA
- Industry
- Enrollment
- 880 participants
Conditions and interventions
Conditions
Interventions
- Certolizumab Pegol Biological
- Methotrexate Biological
- Placebo Other
Biological · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2011
- Primary completion
- Jun 30, 2014
- Completion
- Aug 31, 2015
- Last update posted
- Jul 30, 2018
2012 – 2015
United States locations
- U.S. sites
- 70
- U.S. states
- 31
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 209 | Birmingham | Alabama | — | — |
| 170 | Huntsville | Alabama | — | — |
| 180 | Mobile | Alabama | — | — |
| 247 | Glendale | Arizona | — | — |
| 165 | Paradise Valley | Arizona | — | — |
| 234 | Paradise Valley | Arizona | — | — |
| 243 | Phoenix | Arizona | — | — |
| 251 | Tucson | Arizona | — | — |
| 160 | Covina | California | — | — |
| 257 | Hemet | California | — | — |
| 159 | Los Angeles | California | — | — |
| 201 | San Leandro | California | — | — |
| 202 | Upland | California | — | — |
| 172 | Whittier | California | — | — |
| 190 | Fort Lauderdale | Florida | — | — |
| 196 | Jupiter | Florida | — | — |
| 238 | Lake Mary | Florida | — | — |
| 232 | Miami | Florida | — | — |
| 213 | Naples | Florida | — | — |
| 214 | Ocala | Florida | — | — |
| 237 | Orange Park | Florida | — | — |
| 255 | Orlando | Florida | — | — |
| 163 | Palm Harbor | Florida | — | — |
| 166 | Plantation | Florida | — | — |
| 192 | Sarasota | Florida | — | — |
| 200 | Vero Beach | Florida | — | — |
| 226 | Coeur d'Alene | Idaho | — | — |
| 244 | Springfield | Illinois | — | — |
| 224 | South Bend | Indiana | — | — |
| 215 | Cedar Rapids | Iowa | — | — |
| 191 | Wichita | Kansas | — | — |
| 210 | Wichita | Kansas | — | — |
| 177 | Hagerstown | Maryland | — | — |
| 199 | Kalamazoo | Michigan | — | — |
| 198 | Eagan | Minnesota | — | — |
| 203 | Tupelo | Mississippi | — | — |
| 179 | St Louis | Missouri | — | — |
| 181 | Lincoln | Nebraska | — | — |
| 256 | Reno | Nevada | — | — |
| 229 | Lebanon | New Hampshire | — | — |
| 228 | Clifton | New Jersey | — | — |
| 207 | Albuquerque | New Mexico | — | — |
| 176 | Brooklyn | New York | — | — |
| 242 | Plainview | New York | — | — |
| 227 | Rochester | New York | — | — |
| 236 | Durham | North Carolina | — | — |
| 245 | Middleburg Heights | Ohio | — | — |
| 241 | Oklahoma City | Oklahoma | — | — |
| 186 | Portland | Oregon | — | — |
| 195 | Bethlehem | Pennsylvania | — | — |
| 167 | Duncansville | Pennsylvania | — | — |
| 168 | Wyomissing | Pennsylvania | — | — |
| 189 | Charleston | South Carolina | — | — |
| 205 | Columbia | South Carolina | — | — |
| 204 | Hendersonville | Tennessee | — | — |
| 217 | Allen | Texas | — | — |
| 185 | Amarillo | Texas | — | — |
| 161 | Austin | Texas | — | — |
| 178 | Corpus Christi | Texas | — | — |
| 162 | Dallas | Texas | — | — |
| 184 | Houston | Texas | — | — |
| 206 | Houston | Texas | — | — |
| 223 | Houston | Texas | — | — |
| 158 | Mesquite | Texas | — | — |
| 175 | Nassau Bay | Texas | — | — |
| 249 | Plano | Texas | — | — |
| 197 | San Antonio | Texas | — | — |
| 233 | Kennewick | Washington | — | — |
| 183 | Clarksburg | West Virginia | — | — |
| 174 | Glendale | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 108 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01519791, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2018 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01519791 live on ClinicalTrials.gov.